Grow your data science skills at posit::conf(2023)

September 17th-20th in Chicago


The future of pharma is open source

scientist in a lab looking at a biological culture, another person out of focus in background

An industry-wide shift across every organization

For new talent

Data scientists graduating today expect languages like R and Python to be the backbone of tools used in clinical trials.

For leaders

Leaders responsible for driving innovation across project portfolios and bringing therapeutics to patients faster are training their workforces on open-source tools.

For regulators

Regulators like the FDA are embracing the possibility of freeing the evidence of analysis of beneficial drugs from being locked behind proprietary tools.

Customer Spotlight

GSK logo

"I think the possibility now with open source and particularly something like R, where you've got a tool like Shiny, is you can start to deliver that submission in a different way. I think we'll be sharing the data directly with the regulators in the future, we'll be worried less about how we format that and get it to look really nice on a piece of paper."

Andy Nicholls

Senior Director, Head of Statistical Data Sciences at GSK

Open source is driving clinical trials forward

Big pharma, innovating with open source

Janssen, Pharmaceutical Company of Johnson & Johnson - Logo Roche Logo Pfizer Logo GSK logo AstraZeneca logo Lilly logo

Scale Open Source

Posit Team

An all-in-one solution for open-source teams.
Posit Team logo on dark gray background

Learn R & Python

Posit Academy

Keep pace with industry leaders.
Posit Academy logo on dark gray background

We're experts at helping leading pharmaceutical companies implement open-source into complex clinical workflows.

Let us help you understand the tools you should be using and the skills you need to teach your workforce, so you can bring drugs to market quicker and more confidently.